microRNA 6739-5p (miR-6739-5p) (miR-6739-5p)

microRNA 6739-5p (miR-6739-5p) is a small non-coding RNA that acts as a post-transcriptional regulator of gene expression by binding to target messenger RNAs (mRNAs) [1, 6]. This interaction typically leads to the degradation of the target mRNA or the inhibition of its translation, thereby silencing specific genes [1, 10]. miR-6739-5p is notably involved in the regulation of spermatogenesis, and its down-regulation in seminal plasma is a significant finding in patients with asthenozoospermia, making it a potential diagnostic biomarker and therapeutic target for male infertility [1, 6]. It is also associated with several key intracellular signaling pathways, including PI3K-Akt, MAPK, and FoxO, which are critical for cell survival and proliferation [6]. Beyond reproductive health, miR-6739-5p has been identified as a prognostic biomarker in head and neck squamous cell carcinoma and is implicated in the progression of other malignancies such as non-small cell lung cancer and hepatocellular carcinoma [4, 8]. It also shows sensitivity to ionizing radiation, suggesting a role as a biomarker for radiation exposure and biodosimetry [2, 11]. While there are currently no approved pharmacological agents that specifically target miR-6739-5p, it remains a subject of research for miRNA-based therapeutic strategies, including the use of synthetic mimics to restore its regulatory function in disease states where it is deficient [1, 6]. The multi-target nature of this miRNA provides opportunities for modulating complex disease pathways but also presents challenges regarding off-target effects and tissue-specific delivery [1, 3].

Other names

hsa-miR-6739-5pMIR6739microRNA 6739

Post-transcriptional gene silencing through mRNA degradation or translational inhibition of target genes involved in PI3K-Akt, MAPK, and FoxO signaling pathways.